Prime Therapeutics Report | Summer 2025
Duchenne muscular dystrophy
Ophthalmic anti-VEGF agents
Biosimilar update
ATTR-CM
SP EC I A LTY S O LU TI O N S FO R MANAG ED CARE
Prime Therapeutics S U M M E R 2025
HIV: New treatments and payer management
Report